Key facts
- Scandinavian Biolabs’s last known valuation is $28.9M (Sep 2024).
- It has raised $5.7M; the latest was PE Growth/Expansion ($4.8M) in Jan 2025.
- Notable investors include Five Seasons Ventures, Auréa Group, Blazar Capital, SevenVentures, Synergetic (Italy).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Scandinavian Biolabs
- ·The full record, as it builds
Funding rounds
No funding rounds for Scandinavian Biolabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Scandinavian Biolabs
Operator of a bio-cosmetic company intended to offer hair growth and loss prevention products. The company's products are made of plant-based ingredients including shampoo, conditioner, and serum for both men and women, enabling customers to reduce hair loss and promote overall scalp health.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Copenhagen, Denmark
- Founded
- 2020
- Employees
- 39
- Website
- scandinavianbiolabs.com/
- Ownership
- Privately Held (backing)
Scandinavian Biolabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Scandinavian Biolabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Scandinavian Biolabs in its N-PORT filings yet. We sweep new filings monthly.